Request Deal Involvement
Novartis completed the acquisition of Anthos Therapeutics from Blackstone Life Sciences for $3.1bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Goldman Sachs
legal advisors
Goodwin Procter
financial advisors
Morgan Stanley
legal advisors
Ropes & Gray
legal advisors
Cleary Gottlieb Steen & Hamilton
or
Principals
target
ANTHOS THERAPEUTICS
bidder
NOVARTIS AG
vendor
BLACKSTONE LIFE SCIENCES
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite